{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T10:04:14Z","timestamp":1788084254755,"version":"build-2784847793"},"reference-count":29,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Cerebrospinal fluid (CSF) neopterin reflects inflammation of the central nervous system (CNS) and is a potentially useful biomarker for neuroinflammatory assessment and differential diagnosis. However, its optimal cut-off level in adult patients with neurological disease has not been established and it has not been adequately studied in controls. We aimed to determine its usefulness as a biomarker of neuroinflammation and the effect of age on its level. Methods: In this retrospective study, CSF neopterin was evaluated in 652 patients in 38 disease groups. Its levels were analyzed with high-performance liquid chromatography with fluorometric detection. Results: A receiver operating characteristic analysis revealed that the optimal cut-off value of 33.57 pmol\/mL for CSF neopterin distinguished the control and meningitis\/encephalitis groups with a sensitivity of 100.0% and specificity of 94.4%. In the control group, which consisted of 170 participants (99 men and 71 women; mean \u00b1 standard deviation age, 52.56 \u00b1 17.99 years), age was significantly positively correlated with CSF protein (r = 0.474, p &lt; 0.001) and CSF neopterin (r = 0.476, p &lt; 0.001) levels but not with CSF cell count (r = 0.144, p = 0.061). Both male and female controls exhibited significant increases in CSF neopterin levels with age. Similarly, the CSF neopterin level was significantly positively correlated with age in patients with amyotrophic lateral sclerosis, independently of disease duration and respiratory function. Conclusions: CSF neopterin levels were elevated in patients with various CNS diseases, reflecting CNS inflammation; they were also elevated with age. Prospective studies are required to establish CSF neopterin as a sensitive biomarker of neuroinflammation.<\/jats:p>","DOI":"10.3390\/jcm13154542","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T13:57:28Z","timestamp":1722866248000},"page":"4542","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["CSF Neopterin Levels Are Elevated in Various Neurological Diseases and Aging"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6954-591X","authenticated-orcid":false,"given":"Noriyuki","family":"Miyaue","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, Tohon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamanishi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, Tohon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, Tohon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, Tohon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, Tohon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/clinchem\/44.1.161","article-title":"Neopterin concentrations in cerebrospinal fluid and serum as an aid in differentiating central nervous system and peripheral infections in children","volume":"44","author":"Millner","year":"1998","journal-title":"Clin. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1017\/S1092852919000981","article-title":"Cerebrospinal fluid biomarkers in patients with central nervous system infections: A retrospective study","volume":"25","author":"Alcantarini","year":"2020","journal-title":"CNS Spectr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s11011-019-00452-x","article-title":"Neuronal damage and neuroinflammation markers in patients with autoimmune encephalitis and multiple sclerosis","volume":"34","author":"Fominykh","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Sato, T., Coler-Reilly, A., Utsunomiya, A., Araya, N., Yagishita, N., Ando, H., Yamauchi, J., Inoue, E., Ueno, T., and Hasegawa, Y. (2013). CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy\/tropical spastic paraparesis. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002479"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1002\/cam4.1581","article-title":"The diagnostic role and dynamic changes in cerebrospinal fluid neopterin during treatment of patients with primary central nervous system lymphoma","volume":"7","author":"Geng","year":"2018","journal-title":"Cancer Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"577396","DOI":"10.1016\/j.jneuroim.2020.577396","article-title":"Three cases of rheumatoid meningitis with elevated CSF neopterin levels","volume":"348","author":"Miyaue","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"120385","DOI":"10.1016\/j.jns.2022.120385","article-title":"Clinical use of CSF neopterin levels in CNS demyelinating diseases","volume":"441","author":"Miyaue","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Molero-Luis, M., Fern\u00e1ndez-Ure\u00f1a, S., Jord\u00e1n, I., Serrano, M., Ormaz\u00e1bal, A., Garcia-Cazorla, \u00c0., Artuch, R., and Neopterin Working Group (2013). Cerebrospinal fluid neopterin analysis in neuropediatric patients: Establishment of a new cut off-value for the identification of inflammatory-immune mediated processes. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0083237"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Molero-Luis, M., Casas-Alba, D., Orellana, G., Ormazabal, A., Sierra, C., Oliva, C., Valls, A., Velasco, J., Launes, C., and Cuadras, D. (2020). Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-75500-z"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.freeradbiomed.2017.11.022","article-title":"Neopterin preconditioning prevents inflammasome activation in mammalian astrocytes","volume":"115","author":"Ghisoni","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.mayocp.2022.10.012","article-title":"Population-based evaluation of total protein in cerebrospinal fluid","volume":"98","author":"Fautsch","year":"2023","journal-title":"Mayo Clin. Proc."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Guest, J., Grant, R., Mori, T.A., and Croft, K.D. (2014). Changes in oxidative damage, inflammation and [NAD(H)] with age in cerebrospinal fluid. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085335"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/neuonc\/nov092","article-title":"CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma","volume":"17","author":"Viaccoz","year":"2015","journal-title":"Neuro Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-6405-7-15","article-title":"Cerebrospinal fluid neopterin: An informative biomarker of central nervous system immune activation in HIV-1 infection","volume":"7","author":"Hagberg","year":"2010","journal-title":"AIDS Res. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0022-510X(92)90113-Y","article-title":"Significance of CSF total neopterin and biopterin in inflammatory neurological diseases","volume":"111","author":"Furukawa","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10875-022-01407-1","article-title":"Juvenile neuropsychiatric systemic lupus erythematosus: Identification of novel central neuroinflammation biomarkers","volume":"43","author":"Labouret","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/03009740310000067","article-title":"Serum and salivary neopterin and interferon-gamma in primary Sj\u00f6gren\u2019s syndrome. Correlation with clinical, laboratory and histopathologic features","volume":"32","author":"Sfriso","year":"2003","journal-title":"Scand. J. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ong, L.T.C., Galambos, G., and Brown, D.A. (2017). Primary Sjogren\u2019s syndrome associated with treatment-resistant obsessive-compulsive disorder. Front. Psychiatry, 8.","DOI":"10.3389\/fpsyt.2017.00124"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1469-8749.2008.03225.x","article-title":"Cerebrospinal fluid neopterin in paediatric neurology: A marker of active central nervous system inflammation","volume":"51","author":"Dale","year":"2009","journal-title":"Dev. Med. Child. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-022-02584-x","article-title":"Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases","volume":"19","author":"Boyd","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hu, W.T., Howell, J.C., Ozturk, T., Gangishetti, U., Kollhoff, A.L., Hatcher-Martin, J.M., Anderson, A.M., and Tyor, W.R. (2019). CSF cytokines in aging, multiple sclerosis, and dementia. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00480"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1016\/j.cell.2022.11.019","article-title":"Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment","volume":"185","author":"Piehl","year":"2022","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/jnc.13496","article-title":"Central kynurenine pathway shift with age in women","volume":"136","author":"Guest","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389200024605082","article-title":"Neopterin as a marker for immune system activation","volume":"3","author":"Murr","year":"2002","journal-title":"Curr. Drug Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2169\/internalmedicine.38.133","article-title":"Adenosine and neopterin levels in cerebrospinal fluid of patients with neurological disorders","volume":"38","author":"Yoshida","year":"1999","journal-title":"Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12974-016-0636-1","article-title":"Cerebrospinal fluid levels of neopterin are elevated in delirium after hip fracture","volume":"13","author":"Hall","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/ene.15237","article-title":"Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosis","volume":"29","author":"Shepheard","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00313720","article-title":"Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis","volume":"231","author":"Leonardi","year":"1984","journal-title":"J. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/jnnp.2005.072660","article-title":"Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS Clinic population","volume":"77","author":"Czaplinski","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/15\/4542\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:29:35Z","timestamp":1760110175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/15\/4542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,3]]},"references-count":29,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["jcm13154542"],"URL":"https:\/\/doi.org\/10.3390\/jcm13154542","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,3]]}}}